4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-24-002947
Chief Financial Officer sold 1,590 shares at $1.69 ($2,687)
- Chief Financial Officer acquired 3,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Broadfoot Jill Marie Chief Financial Officer | 2024-02-05 | Option exercise | +3,750 | 22,411 | D | ||
| Broadfoot Jill Marie Chief Financial Officer | 2024-02-06 | Sale | −1,590 | $1.69 | $2,687 | 20,821 | D |
| Derivatives | |||||||
| Broadfoot Jill Marie Chief Financial Officer | 2024-02-05 | Option exercise · Restricted Stock Unit | −3,750 | 7,500 | D | ||
| Open-market sales · 1,590 sh · avg $1.69 · $2,687 | |||||||
Loading xslF345X05/doc4.xml…